Symplicity HTN-3 Clinical Trial | Heart and Vascular Health |

Website from the manufacturer Medtronic sponsoring the US trial for renal denervation in resistent hypertension.  This device is available for use in Australia, Canada and Europe, but not yet approved in the US.  The trial Symplicity HTN-3 is a US Pivotal trial for American patients with resistant hypertension defined as blood pressure greater than 160 despite at least 3 maximum dose medications including at least one diuretic.  The trial section gives patients an opportunity to see if they are candidates fotr the trial.